253 related articles for article (PubMed ID: 3061778)
1. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
Ievleva ES; Ermoshina NV; Ageenko AI
Eksp Onkol; 1988; 10(5):33-5. PubMed ID: 3061778
[TBL] [Abstract][Full Text] [Related]
2. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
[TBL] [Abstract][Full Text] [Related]
3. Cervical carcinoma antigens in the diagnosis of human squamous cell carcinoma of the cervix.
Haines HG; McCoy JP; Hofheinz DE; Ng AB; Nordqvist SR; Leif RC
J Natl Cancer Inst; 1981 Mar; 66(3):465-74. PubMed ID: 7009947
[TBL] [Abstract][Full Text] [Related]
4. [Immunocytochemical detection of antigen associated with squamous cell cancer of the cervix uteri in women].
Ievleva ES; Marshutina NV; Ageenko AI; Tsukerman BG
Eksp Onkol; 1990; 12(4):65-7. PubMed ID: 2199188
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
6. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
7. [A tumor-associated antigen of cervical cancer].
Ermoshina NV; Ievleva ES; Ageenko AI; Kogan IIa; Tsukerman BG
Eksp Onkol; 1986; 8(2):48-51. PubMed ID: 3084195
[TBL] [Abstract][Full Text] [Related]
8. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: implications for tumor marker detection.
Barnes RC; Coulter J; Worrall DM
Gynecol Oncol; 2000 Jul; 78(1):62-6. PubMed ID: 10873412
[TBL] [Abstract][Full Text] [Related]
10. [The clinical usefulness of SCC antigen for diagnosis of recurrent cervical squamous cancer].
Umezawa S; Takeshima N; Shimizu Y; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):165-8. PubMed ID: 7706858
[No Abstract] [Full Text] [Related]
11. Immunocytochemical staining of cervical smears for the diagnosis of cervical intraepithelial neoplasia.
Moncrieff D; Ormerod MG; Coleman DV
Anal Quant Cytol; 1984 Sep; 6(3):201-5. PubMed ID: 6391321
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical studies on a new antigens associated with squamous cell cancer in oncogenesis of uterine cervical cancer].
Uchimura M; Kenjo T; Kuroshima Y; Fujii A; Yamauchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jan; 43(1):73-9. PubMed ID: 1997617
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
Ngan HY; Cheng GT; Yeung WS; Wong LC; Ma HK
Gynecol Oncol; 1994 Jan; 52(1):63-8. PubMed ID: 8307503
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of SCC antigen assay as a tumor marker].
Kato H
Nihon Rinsho; 1990 Feb; 48 Suppl():1057-9. PubMed ID: 2192106
[No Abstract] [Full Text] [Related]
16. [Tumor marker squamous cell carcinoma antigen].
Lavie O; Neuman M; Zuckerman B; Hornreich G; Beller U
Harefuah; 1998 Sep; 135(5-6):222-5. PubMed ID: 9885641
[No Abstract] [Full Text] [Related]
17. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
[TBL] [Abstract][Full Text] [Related]
18. [An immunohistological study on expression of glutathione S-transferase pi (form) in dysplastic and neoplastic human uterine cervix lesions].
Satoh T; Nishida M; Oki A; Ichikawa Y; Tsunoda H; Kubo T
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):522-8. PubMed ID: 8754394
[TBL] [Abstract][Full Text] [Related]
19. [Squamous cell carcinoma antigen--a useful tumor marker for gynecologic squamous cell cancers?].
Neunteufel W; Tatra G; Reinthaller A; Bieglmayer C
Gynakol Rundsch; 1988; 28 Suppl 2():201-2. PubMed ID: 3234918
[No Abstract] [Full Text] [Related]
20. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
